A novel neutralizing human monoclonal antibody broadly abrogates hepatitis C virus infection in vitro and in vivo

Infections with hepatitis C virus (HCV) represent a worldwide health burden and a prophylactic vaccine is still not available. Liver transplantation (LT) is often the only option for patients with HCV-induced end-stage liver disease. However, immediately after transplantation, the liver graft become...

Descripción completa

Detalles Bibliográficos
Autores principales: Desombere, Isabelle, Mesalam, Ahmed Atef, Urbanowicz, Richard A., Van Houtte, Freya, Verhoye, Lieven, Keck, Zhen-Yong, Farhoudi, Ali, Vercauteren, Koen, Weening, Karin E., Baumert, Thomas F., Patel, Arvind H., Foung, Steven K.H., Ball, Jonathan, Leroux-Roels, Geert, Meuleman, Philip
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5785094/
https://www.ncbi.nlm.nih.gov/pubmed/29074219
http://dx.doi.org/10.1016/j.antiviral.2017.10.015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5785094/
https://www.ncbi.nlm.nih.gov/pubmed/29074219
http://dx.doi.org/10.1016/j.antiviral.2017.10.015

Ejemplares similares